RA
Rosalind Advisors Portfolio holdings
AUM
$207M
This Quarter Return
+39.95%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
–
Cap. Flow
+$120M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
62.88%
Holding
29
New
27
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Lyra Therapeutics
LYRA
|
$9.9M |
| 2 |
Myomo
MYO
|
$9.62M |
| 3 |
Astria Therapeutics
ATXS
|
$8.67M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$8.33M |
| 5 |
Viridian Therapeutics
VRDN
|
$7.85M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Geron
GERN
$893M
| $422K | 0.35% | +200,000 | New | +$422K |
|
27
Tonix Pharmaceuticals
TNXP
$260M
| $363K | 0.3% | +900,900 | New | +$363K |
|
28
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
29
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|